Xun Zhang
Geen lopende functies
Profiel
Xun Zhang worked as a Senior Vice President-Project Operations at Hutchison MediPharma Ltd.
from 2005 to 2012.
Prior to that, he worked as a Director-Pharmaceutical Sciences Division at Pfizer Inc. and as a Principal at Bristol Myers Squibb Co. Dr. Zhang received his undergraduate degree from Peking University and his doctorate degree from The University of Texas at Austin.
Eerdere bekende functies van Xun Zhang
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Operationeel Directeur | - |
Opleiding van Xun Zhang
| The University of Texas at Austin | Doctorate Degree |
| Peking University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
